je.st
news
GlaxoSmithKline Pharma loses patent claim on breast cancer drug Tykerb
2013-08-02 16:15:06| Biotech - Topix.net
The Intellectual Property Appellate Board has revoked the patent granted to the British drug major Glaxosmithkline Pharma Ltd for its breast cancer drug - Tykerb.
Tags: drug
claim
cancer
patent
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||